Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer's disease.


Teva Pharmaceutical Industries, donepezil hydrochloride tablets, Aricept, generic version, Eisai, Alzheimer's disease


































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Teva begins shipping generic of Aricept

June 1st, 2011

JERUSALEM – Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer's disease.

The company said Wednesday that it has received Food and Drug Administration approval to market a generic version of Eisai's Aricept Tablets in strengths of 5 mg and 10 mg.

According to Teva, annual sales of the drug, including branded and generic sales, total approximately $2.3 billion in the United States, based on IMS Health data.

Advertisement